Graceway Pharmaceuticals (European Rights of Zyclara) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Graceway Pharmaceuticals (European Rights of Zyclara) General Information

Description

A medicinal formula for imiquimod topical cream. The company engages in the formulation and manufacture of medicinal cream used for the treatment of actinic keratosis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Personal Products
Pharmaceuticals
Acquirer
Primary Office
  • 340 Martin Luther King Junior Boulevard
  • Suite 500
  • Bristol, TN 37620
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Graceway Pharmaceuticals (European Rights of Zyclara) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Graceway Pharmaceuticals (European Rights of Zyclara)‘s full profile, request access.

Request a free trial

Graceway Pharmaceuticals (European Rights of Zyclara) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Graceway Pharmaceuticals (European Rights of Zyclara)‘s full profile, request access.

Request a free trial